1751-24-2

Basic information

• Product Name: METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE
• Synonyms: METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE
• CAS NO: 1751-24-2
• Molecular Formula: C₁₁H₁₀O₄
• Molecular Weight: 206.196
• Mol File: 1751-24-2.mol
• Article Data: 10

Chemical Properties

• Appearance: /
• CAS DataBase Reference: METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE(1751-24-2)
• EPA Substance Registry System: METHYL 5-METHOXYBENZOFURAN-2-CARBOXYLATE(1751-24-2)

Safety Data

• Hazardous Substances Data: 1751-24-2(Hazardous Substances Data)

Upstream product

• 672-13-9 2-hydroxy-5-methoxybenzaldehyde 
• 96-32-2 bromoacetic acid methyl ester 
• 67-56-1 methanol 
• 10242-08-7 5-methoxybenzofuran-2-carboxylic acid 
• 1649501-84-7 methyl (Z)-2-(4-methoxyphenoxy)-3-(dimethylamino)acrylate 
• 79704-02-2 (4-methoxyphenoxy)acetic acid methyl ester 
• 150-76-5 4-methoxy-phenol 

Downstream Products

• 1646-28-2 5-hydroxy-benzofuran-2-carboxylic acid methyl ester 
• 155587-71-6 6-Amino-5-hydroxybenzofuran-2-carbonsaeure-methylester 
• 1027017-24-8 2-{cyclohexyl-[5-(quinolin-2-ylmethoxy)-benzofuran-2-yl]-methoxy}-isoindole-1,3-dione 
• 1026457-69-1 O-{cyclohexyl-[5-(quinolin-2-ylmethoxy)-benzofuran-2-yl]-methyl}-hydroxylamine 
• 1026925-87-0 cyclohexyl-[5-(quinolin-2-ylmethoxy)-benzofuran-2-yl]-methanol 
• 653578-09-7 5-{3-[2-chloro-4-(2,2,2-trifluoro-ethoxy)-phenoxy]-propoxy}-2-methyl-2,3-dihydro-benzofuran-2-carboxylic acid methyl ester 

Relevant articles and documents

AMIDE COMPOUND HAVING BET PROTEOLYSIS-INDUCING ACTION AND MEDICINAL APPLICATION THEREOF

The present invention aims to provide a compound that: has an excellent cytotoxic action on cancer cells, excellent induction of BET protein degradation in cancer cells, and an excellent binding-inhibiting action on BET protein and acetylated histone; and is effective as an anti-cancer agent, a BET protein degradation-inducing agent, or a BET protein inhibiting agent. A compound indicated in general formula (I) or a pharmacologically acceptable salt thereof. {In the formula, each symbol is as outlined in the Description.}

AMINOPYRIMIDINE DERIVATIVES AS LRRK2 MODULATORS

Compounds of the formula (I): or pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R3 and R4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for t

NOVEL SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS

The present invention is directed to saframcyin analogs that are useful in the treatment of cancer. Pharmaceutical compositions and processes for preparing these compounds are also disclosed.